Unibest 优贝德
← Back to patent-cliff list

CAS 110-16-7

maleic acid

Codes:AVAT-011、AFAT-018

Application context (from source-drug indications)

血小板减少马来酸阿伐曲泊帕特发性血小板减少性紫癜马来酸阿伐曲泊帕肝脏疾病马来酸阿伐曲泊帕非小细胞肺癌马来酸阿法替尼头颈部鳞状细胞癌马来酸阿法替尼头颈癌马来酸阿法替尼脊索瘤马来酸阿法替尼鳞状细胞癌马来酸阿法替尼胆囊癌马来酸阿法替尼

Source drugs (routes using this intermediate)

DrugTierExpiry
马来酸阿伐曲泊帕Avatrombopag MaleateTier C — Watch / trade2030
马来酸阿法替尼Afatinib DimaleateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Qualified Partner — East China API Works4-(4-chloro-2-thienyl)-2-ThiazolaMine
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP Site4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site1-Cyclohexylpiperazine
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Works5,6-Dichloronicotinic acid
Pharmaceutical Intermediates
询价询价询价
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.